Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer.

McCaughan GJ, Blinman PL, Boyer MJ, Stockler MR.

Intern Med J. 2013 Apr;43(4):424-9. doi: 10.1111/j.1445-5994.2012.02846.x.

PMID:
22647141
2.

Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: a systematic review of contemporary randomized trials.

Kiely BE, Alam M, Blinman P, Tattersall MH, Stockler MR.

Lung Cancer. 2012 Sep;77(3):537-44. doi: 10.1016/j.lungcan.2012.04.017. Epub 2012 May 18. Review.

PMID:
22609149
3.

The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer.

Tsuboi M, Ohira T, Saji H, Miyajima K, Kajiwara N, Uchida O, Usuda J, Kato H.

Ann Thorac Cardiovasc Surg. 2007 Apr;13(2):73-7. Review.

PMID:
17505412
5.
6.

Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.

Johnson BE, Rabin MS.

Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5022s-5026s. Review.

7.

Adjuvant chemotherapy for completely resected non-small-cell lung cancer.

Suehisa H, Toyooka S.

Acta Med Okayama. 2009 Oct;63(5):223-30. Review.

8.

Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.

Park JH, Lee CT, Lee HW, Baek HJ, Zo JI, Shim YM.

Eur J Cardiothorac Surg. 2005 Jun;27(6):1086-91. Epub 2005 Mar 2.

PMID:
15896623
9.

Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial.

Bennouna J, Senellart H, Hiret S, Vaissiere N, Douillard JY.

Lung Cancer. 2011 Oct;74(1):30-4. doi: 10.1016/j.lungcan.2011.02.004. Epub 2011 Mar 3.

PMID:
21371774
10.

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR.

J Clin Oncol. 2008 Nov 1;26(31):5043-51. doi: 10.1200/JCO.2008.16.4855. Epub 2008 Sep 22.

11.

Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).

Tanaka F, Miyahara R, Ohtake Y, Yanagihara K, Fukuse T, Hitomi S, Wada H.

Eur J Cardiothorac Surg. 1998 Sep;14(3):256-62; discussion 263-4.

PMID:
9761434
12.

Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer.

Park SY, Lee JG, Kim J, Byun GE, Bae MK, Lee CY, Kim DJ, Chung KY.

J Cardiothorac Surg. 2013 Jun 11;8:151. doi: 10.1186/1749-8090-8-151.

13.

Adjuvant chemotherapy for surgically resected non-small cell lung cancer.

Heon S, Johnson BE.

J Thorac Cardiovasc Surg. 2012 Sep;144(3):S39-42. doi: 10.1016/j.jtcvs.2012.03.039. Epub 2012 Apr 13. Review.

14.

Adjuvant chemotherapy for radically resected non-small cell lung cancer: a retrospective analysis of 311 consecutively treated patients.

Dediu M, Horvat T, Tarlea A, Anghel R, Cordos I, Miron G, Iorga P, Alexandru A, Nistor C, Grozavu C, Savu C.

Lung Cancer. 2005 Jan;47(1):93-101.

PMID:
15603859
15.

Adjuvant chemotherapy for early-stage non-small-cell lung cancer. Single-centre experience and literature review.

Custodio Carretero AB, García Sáenz JA, González Larriba JL, Bobokova J, Calles Blanco A, Hernando Trancho F, García Paredes B, Rodríguez Lajusticia L, Díaz-Rubio García E.

Clin Transl Oncol. 2008 Sep;10(9):560-71.

PMID:
18796373
16.

A systematic overview of chemotherapy effects in non-small cell lung cancer.

Sörenson S, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):327-39. Review.

PMID:
11441939
17.

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M, et al.

J Natl Cancer Inst. 1994 May 4;86(9):673-80.

PMID:
8158698
18.

Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).

Lee SW, Choi EK, Chung WK, Shin KH, Ahn SD, Kim JH, Kim SW, Suh C, Lee JS, Kim WS, Kim DS, Kim DK, Park SI, Sohn KH.

Lung Cancer. 2002 Jul;37(1):65-71.

PMID:
12057869
19.

Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift.

Betticher DC.

Lung Cancer. 2005 Dec;50 Suppl 2:S9-16. Review.

PMID:
16557669
20.

[Adjuvant chemotherapy for non-small cell lung cancer].

Okamoto T, Ichinose Y.

Gan To Kagaku Ryoho. 2006 Dec;33(13):1985-90. Review. Japanese.

PMID:
17197740

Supplemental Content

Support Center